Catalyst Wire Dossier Catalyst Wire Dossier

Arzoxifene hydrochloride

arzoxifene hydrochloride · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Arzoxifene hydrochloride, covering 2012-06-07 to 2012-06-07. Get the full timeline:

Most recent: Clinical Trial Update: Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer [Phase 2]

See pricing